Polyamine depletion therapy in prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-12

AUTHORS

BH Devens, RS Weeks, Burns, CL Carlson, MK Brawer

ABSTRACT

The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279 More... »

PAGES

4500420

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420

DOI

http://dx.doi.org/10.1038/sj.pcan.4500420

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011980478

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12497077


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devens", 
        "givenName": "BH", 
        "id": "sg:person.01026125710.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026125710.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weeks", 
        "givenName": "RS", 
        "id": "sg:person.011117074662.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011117074662.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burns", 
        "id": "sg:person.0644237665.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644237665.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Oridigm Corporation, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carlson", 
        "givenName": "CL", 
        "id": "sg:person.0576124465.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576124465.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwest Hospital and Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.416561.1", 
          "name": [
            "Northwest Prostate Institute, Northwest Hospital, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brawer", 
        "givenName": "MK", 
        "id": "sg:person.01026200644.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026200644.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3109/07853899109148056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021572844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-0-12-481835-4.50020-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028226153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-4347(00)83621-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044066151"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-12", 
    "datePublishedReg": "2000-12-01", 
    "description": "The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.pcan.4500420", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1119336", 
        "issn": [
          "1365-7852", 
          "1476-5608"
        ], 
        "name": "Prostate Cancer and Prostatic Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "name": "Polyamine depletion therapy in prostate cancer", 
    "pagination": "4500420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3914f5d1397b173913546fa24b0624fb960429964be54185eedb7c5ba94d1ab9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12497077"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9815755"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.pcan.4500420"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011980478"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.pcan.4500420", 
      "https://app.dimensions.ai/details/publication/pub.1011980478"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/4500420"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500420'


 

This table displays all metadata directly associated to this object as RDF triples.

113 TRIPLES      21 PREDICATES      32 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.pcan.4500420 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N1a5a4e55ba6548aa8fae588fba91fc38
4 schema:citation https://doi.org/10.1016/b978-0-12-481835-4.50020-x
5 https://doi.org/10.1016/s0378-4347(00)83621-x
6 https://doi.org/10.3109/07853899109148056
7 schema:datePublished 2000-12
8 schema:datePublishedReg 2000-12-01
9 schema:description The prostate gland has among the highest level of polyamines in the body and prostate carcinomas have even greater elevated polyamine levels. These ubiquitous molecules synthesized by prostate epithelium are involved in many biochemical processes including cellular proliferation, cell cycle regulation, and protein synthesis. These properties have made polyamines a potential target for therapeutic intervention in diseases of excessive cell proliferation such as cancer. However, attempts to limit tumor growth by inhibition of polyamine synthesis have not been very successful since cells have the capacity to take up polyamines from the bloodstream. We report here studies utilizing polyamine depletion by means of a combination of blockade of polyamine synthesis with DFMO (alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase, the rate limiting enzyme in the polyamine synthetic pathway, and ORI 1202, a novel inhibitor of polyamine transport into the cell. This cytostatic combination, even in the presence of excess extracellular polyamines, significantly slowed the growth of the human tumor cell line PC-3 grown in tissue culture with an EC(50) in the &mgr;M range. Other prostate cell lines were similarly growth inhibited including LNCaP.FGC and DU145. Growth of the PC-3 tumor cell line as a xenograft in nude mice was also slowed significantly by this combination of compounds. Polyamine levels in the tumor were lowered from control tumor levels. This combination therapy could provide an effective and potentially non-toxic therapy for prostate tumors.Prostate Cancer and Prostatic Diseases (2000) 3, 275-279
10 schema:genre research_article
11 schema:inLanguage en
12 schema:isAccessibleForFree true
13 schema:isPartOf Nf3fe4b24d45241ee8ffe54d8b2dd6150
14 Nfefb5f4494254879bd1a80100532958d
15 sg:journal.1119336
16 schema:name Polyamine depletion therapy in prostate cancer
17 schema:pagination 4500420
18 schema:productId N41a13213284640f589b012cbfd4ab8c0
19 N5c82f436be47469b9577f253b1d2b8b9
20 Nc82fd6f720484e18966be70517b18526
21 Nca266a43588f4ef3be9756ead3fb2821
22 Neeb06f4f0a864424bf54f6d07000b53d
23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011980478
24 https://doi.org/10.1038/sj.pcan.4500420
25 schema:sdDatePublished 2019-04-10T18:56
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher Nddf4ddc84a414a0b96d6ddd64fd39412
28 schema:url http://www.nature.com/articles/4500420
29 sgo:license sg:explorer/license/
30 sgo:sdDataset articles
31 rdf:type schema:ScholarlyArticle
32 N1a5a4e55ba6548aa8fae588fba91fc38 rdf:first sg:person.01026125710.11
33 rdf:rest N2760fd23ec224f4a8a7cad3b711c59ab
34 N22123d2748fa444daa459ddfa84a3abd schema:name Oridigm Corporation, Seattle, WA, USA
35 rdf:type schema:Organization
36 N2760fd23ec224f4a8a7cad3b711c59ab rdf:first sg:person.011117074662.90
37 rdf:rest Nea3a0c27a2404e28af5eb06a1ca381e7
38 N41a13213284640f589b012cbfd4ab8c0 schema:name readcube_id
39 schema:value 3914f5d1397b173913546fa24b0624fb960429964be54185eedb7c5ba94d1ab9
40 rdf:type schema:PropertyValue
41 N5c82f436be47469b9577f253b1d2b8b9 schema:name doi
42 schema:value 10.1038/sj.pcan.4500420
43 rdf:type schema:PropertyValue
44 N9b64c0e964d144ee8105e23d6d47b659 schema:name Oridigm Corporation, Seattle, WA, USA
45 rdf:type schema:Organization
46 Na30e53d5937e4bbdaec4b6069bf83ea4 rdf:first sg:person.01026200644.85
47 rdf:rest rdf:nil
48 Nc82fd6f720484e18966be70517b18526 schema:name nlm_unique_id
49 schema:value 9815755
50 rdf:type schema:PropertyValue
51 Nca266a43588f4ef3be9756ead3fb2821 schema:name pubmed_id
52 schema:value 12497077
53 rdf:type schema:PropertyValue
54 Nd3359da16e1c4092b419e4ab91e3f652 rdf:first sg:person.0576124465.60
55 rdf:rest Na30e53d5937e4bbdaec4b6069bf83ea4
56 Ndc2e26f8b9424658a31d7e15251b9243 schema:name Oridigm Corporation, Seattle, WA, USA
57 rdf:type schema:Organization
58 Nddf4ddc84a414a0b96d6ddd64fd39412 schema:name Springer Nature - SN SciGraph project
59 rdf:type schema:Organization
60 Ne42e4312fb6b4ebfa7504c8ff1c602aa schema:name Oridigm Corporation, Seattle, WA, USA
61 rdf:type schema:Organization
62 Nea3a0c27a2404e28af5eb06a1ca381e7 rdf:first sg:person.0644237665.63
63 rdf:rest Nd3359da16e1c4092b419e4ab91e3f652
64 Neeb06f4f0a864424bf54f6d07000b53d schema:name dimensions_id
65 schema:value pub.1011980478
66 rdf:type schema:PropertyValue
67 Nf3fe4b24d45241ee8ffe54d8b2dd6150 schema:issueNumber 4
68 rdf:type schema:PublicationIssue
69 Nfefb5f4494254879bd1a80100532958d schema:volumeNumber 3
70 rdf:type schema:PublicationVolume
71 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
72 schema:name Medical and Health Sciences
73 rdf:type schema:DefinedTerm
74 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
75 schema:name Oncology and Carcinogenesis
76 rdf:type schema:DefinedTerm
77 sg:journal.1119336 schema:issn 1365-7852
78 1476-5608
79 schema:name Prostate Cancer and Prostatic Diseases
80 rdf:type schema:Periodical
81 sg:person.01026125710.11 schema:affiliation Ndc2e26f8b9424658a31d7e15251b9243
82 schema:familyName Devens
83 schema:givenName BH
84 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026125710.11
85 rdf:type schema:Person
86 sg:person.01026200644.85 schema:affiliation https://www.grid.ac/institutes/grid.416561.1
87 schema:familyName Brawer
88 schema:givenName MK
89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026200644.85
90 rdf:type schema:Person
91 sg:person.011117074662.90 schema:affiliation N22123d2748fa444daa459ddfa84a3abd
92 schema:familyName Weeks
93 schema:givenName RS
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011117074662.90
95 rdf:type schema:Person
96 sg:person.0576124465.60 schema:affiliation N9b64c0e964d144ee8105e23d6d47b659
97 schema:familyName Carlson
98 schema:givenName CL
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576124465.60
100 rdf:type schema:Person
101 sg:person.0644237665.63 schema:affiliation Ne42e4312fb6b4ebfa7504c8ff1c602aa
102 schema:familyName Burns
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644237665.63
104 rdf:type schema:Person
105 https://doi.org/10.1016/b978-0-12-481835-4.50020-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028226153
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1016/s0378-4347(00)83621-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044066151
108 rdf:type schema:CreativeWork
109 https://doi.org/10.3109/07853899109148056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021572844
110 rdf:type schema:CreativeWork
111 https://www.grid.ac/institutes/grid.416561.1 schema:alternateName Northwest Hospital and Medical Center
112 schema:name Northwest Prostate Institute, Northwest Hospital, Seattle, WA, USA
113 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...